High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$2.9M
$2,922,496
Total Sells (Filtered)
$0
$0
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| AKTX |
Akari Therapeutics Plc
|
Director
Discretionary Buy
|
2025-12-16 | $0 | P | Form 4 |
| AKTX |
Akari Therapeutics Plc
|
Director
Discretionary Buy
|
2025-12-16 | $250,000 | P | Form 4 |
| AKTX |
Akari Therapeutics Plc
|
Director
Discretionary Buy
|
2025-12-16 | $0 | P | Form 4 |
| AKTX |
Akari Therapeutics Plc
|
Director
Discretionary Buy
|
2025-12-16 | $1,250,000Large | P | Form 4 |
| AKTX |
Akari Therapeutics Plc
|
Director
Discretionary Buy
|
2025-12-16 | $0 | P | Form 4 |
| AKTX |
Akari Therapeutics Plc
|
Director
Discretionary Buy
|
2025-12-16 | $50,000 | P | Form 4 |
| AKTX |
Akari Therapeutics Plc
|
Director
Discretionary Buy
|
2025-12-16 | $0 | P | Form 4 |
| AKTX |
Akari Therapeutics Plc
|
Director
Discretionary Buy
|
2025-12-16 | $12,500 | P | Form 4 |
| AKTX |
Akari Therapeutics Plc
|
CEO
Discretionary Buy
|
2025-12-16 | $0 | P | Form 4 |
| AKTX |
Akari Therapeutics Plc
|
CEO
Discretionary Buy
|
2025-12-16 | $124,999 | P | Form 4 |
| AKTX |
Akari Therapeutics Plc
|
CEO
Discretionary Buy
|
2025-12-16 | $0 | P | Form 4 |
| AKTX |
Akari Therapeutics Plc
|
CEO
Discretionary Buy
|
2025-12-16 | $312,500 | P | Form 4 |
| AKTX |
Akari Therapeutics Plc
|
Director
Discretionary Buy
|
2025-12-16 | $0 | P | Form 4 |
|
AKTX
P
Akari Therapeutics Plc
Patel Samir Rashmikant
• Director
Discretionary Buy
2025-12-16
$250,000
|
||||||
| AKTX |
Akari Therapeutics Plc
|
Director
Discretionary Buy
|
2025-12-16 | $250,000 | P | Form 4 |
| AKTX |
Akari Therapeutics Plc
|
Director
Discretionary Buy
|
2025-12-16 | $0 | P | Form 4 |
|
AKTX
P
Akari Therapeutics Plc
Patel Samir Rashmikant
• Director
Discretionary Buy
2025-12-16
$93,750
|
||||||
| AKTX |
Akari Therapeutics Plc
|
Director
Discretionary Buy
|
2025-12-16 | $93,750 | P | Form 4 |
| AKTX |
Akari Therapeutics Plc
|
CFO
Discretionary Buy
|
2025-12-16 | $0 | P | Form 4 |
| AKTX |
Akari Therapeutics Plc
|
CFO
Discretionary Buy
|
2025-12-16 | $9,999 | P | Form 4 |
| AKTX |
Akari Therapeutics Plc
|
Director
Discretionary Buy
|
2025-12-16 | $0 | P | Form 4 |
| AKTX |
Akari Therapeutics Plc
|
Director
Discretionary Buy
|
2025-12-16 | $99,999 | P | Form 4 |
| AKTX |
Akari Therapeutics Plc
|
Director
Discretionary Buy
|
2025-12-16 | $0 | P | Form 4 |
| AKTX |
Akari Therapeutics Plc
|
Director
Discretionary Buy
|
2025-12-16 | $62,500 | P | Form 4 |
| AKTX |
Akari Therapeutics Plc
|
Director
Discretionary Buy
|
2025-12-16 | $0 | P | Form 4 |
|
AKTX
P
Akari Therapeutics Plc
Prudo-Chlebosz Raymond
• Director
Discretionary Buy
2025-12-16
$250,000
|
||||||
| AKTX |
Akari Therapeutics Plc
|
Director
Discretionary Buy
|
2025-12-16 | $250,000 | P | Form 4 |
| AKTX |
Akari Therapeutics Plc
|
Director
Discretionary Buy
|
2025-12-16 | $0 | P | Form 4 |
|
AKTX
P
Akari Therapeutics Plc
Prudo-Chlebosz Raymond
• Director
Discretionary Buy
2025-12-16
$156,250
|
||||||
| AKTX |
Akari Therapeutics Plc
|
Director
Discretionary Buy
|
2025-12-16 | $156,250 | P | Form 4 |